home / stock / cocp / cocp news

COCP News and Press, Cocrystal Pharma Inc. From 03/17/21

Stock Information
Company Name: Cocrystal Pharma Inc.
Stock Symbol: COCP
Market: NASDAQ
Website: cocrystalpharma.com
Menu
COCP COCP Quote COCP Short COCP News COCP Articles COCP Message Board
Get COCP Alerts

News, Short Squeeze, Breakout and More Instantly...
COCP - Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones

Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programs Ends 2020 with cash exceeding $33 million and a clean capital structure BOTHELL, Wash., March 17, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), ...
COCP - Cocrystal Pharma extends drug discovery collaboration with Hitgen and Interx

Cocrystal Pharma (COCP) announces an extension of its drug discovery collaboration with HitGen and computer software company InterX with the agreement now continuing through August 2023.Through the collaboration, Cocrystal, HitGen and InterX scientists are applying HitGenȁ...

COCP - Cocrystal Pharma Extends Drug Discovery Collaboration with HitGen and InterX

BOTHELL, Wash, March 10, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery o...

COCP - Cocrystal Pharma to Participate in the Virtual 33rd Annual Roth Conference

BOTHELL, Wash., March 09, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery ...
COCP - Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference [UPDATED]

BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery ...

COCP - Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machin...

COCP - Cocrystal Pharma Presentation at the reimagine Health Research Symposium Features Overview of Platform Technology and Four Antiviral Case Studies

BOTHELL, Wash., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication mac...
COCP - Cocrystal Pharma (COCP) Investor Presentation -Slideshow

The following slide deck was published by Cocrystal Pharma, Inc. in conjunction with this event. For further details see: Cocrystal Pharma (COCP) Investor Presentation -Slideshow

COCP - 5 Penny Stocks Riding The Biotech Wave In January 2021

Biotech Penny Stocks To Watch This Week If you have been looking at the biotech industry, you’ve likely stumbled upon a few penny stocks. This weekend one of the topics of conversation was the industry and how it has superseded the broader markets. If you look at industry benchma...

COCP - GME, LAC, AMC and COHR among premarket gainers

Tenax Therapeutics, Inc. (TENX) +70% after announcing acquisition of PH Precision Med.Aclaris Therapeutics (ACRS) +66% on positive data from mid-stage rheumatoid arthritis.Minerva Neurosciences (NERV) +42% on announcing sale of Seltorexant Royalty for up to $155M.China Natural ...
Previous 10 Next 10